Kansu Buyukafsar

Prof. Dr. Kansu Buyukafsar

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
SIS Y İnAn
S Y İnAn
KBKansu Buyukafsar
Kansu Buyukafsar
Background and purpose: Rho/Rho‐kinase signalling is involved in many cellular events, including some in the CNS. However, the role of this pathway in epilepsy has not yet been assessed. Therefore, we determined the effects of two Rho‐kinase inhibitors, Y‐27632 and fasudil, on seizures induced by pentylenetetrazole (PTZ) or maximal electroconvulsive shock (MES).Experimental approach: Effects of Y‐27632 (5–10 mg kg−1) and fasudil (5–25 mg kg−1) on duration of myoclonic jerks, clonic and tonic convulsions, tonic hindlimb extensions and percentage of tonic convulsion index, as well as recovery latency for righting reflex were investigated in mice stimulated with PTZ (65 mg kg−1) or MES (50 Hz, 50 mA and 0.4 s). These inhibitors were also tested on a model of kindling induced by PTZ (35 mg kg−1, for 11 days). Membrane and cytosolic levels of RhoA protein were measured in brain homogenates from kindled mice.Key results: Y‐27632 and fasudil diminished onset of myoclonic jerks, clonic convulsions and tonic hindlimb extensions in mice given PTZ. These inhibitors suppressed the percentage of tonic convulsion index and recovery latency for righting reflex in the mice excited with MES. Western blotting demonstrated that Rho translocation to plasma membrane increased in the brain homogenates obtained from PTZ‐kindled mice. However, the Rho‐kinase inhibitors at the given doses did not change motor coordination of the mice.Conclusions and implications: Rho/Rho‐kinase signalling may play a role in epilepsy induced by PTZ and MES. Furthermore, Rho‐kinase inhibitors could be novel important antiepileptic agents.British Journal of Pharmacology (2008) 155, 44–51; doi:10.1038/bjp.2008.225; published online 9 June 2008

1 October 2003 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
KBKansu Buyukafsar
Kansu Buyukafsar
ALAdnan Levent
Adnan Levent
MAMustafa Ark
Mustafa Ark

20 June 2003 in European Journal of Pharmacology
Verified
Journal Article
Closed access
KBKansu Buyukafsar
Kansu Buyukafsar
IÜİsmail Ün
İsmail Ün

1 October 2004 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
ALAdnan Levent
Adnan Levent
KBKansu Buyukafsar
Kansu Buyukafsar

1 October 2001 in Pharmacological Research
Verified
Journal Article
Closed access
KBKansu Buyukafsar
Kansu Buyukafsar
AYAzİz Yazar
Azİz Yazar
DDDuygu Düşmez
Duygu Düşmez
HÖHakan Öztürk
Hakan Öztürk
GPGürbüz Polat
Gürbüz Polat
ALAdnan Levent
Adnan Levent

1 July 2006 in European Journal of Pharmacology
Verified
Journal Article
Closed access
KBKansu Buyukafsar
Kansu Buyukafsar
IYİpek Yalçın
İpek Yalçın
AKA. Hakan Kurt
A. Hakan Kurt
RTR. Nalan Tiftik
R. Nalan Tiftik
SŞSeyhan Şahan-Fırat
Seyhan Şahan-Fırat
FAFazilet Aksu
Fazilet Aksu